Global summary of the HIV/AIDS epidemic, December 2001 Number of people living with HIV/AIDS Total Adults Women Children under 15 years 40 million 37.2 million 17.6 million 2.7 million People newly infected with HIV in 2001 Total Adults Women Children under 15 years 5 million 4.3 million 1.8 million 800 000 AIDS deaths in 2001 Total Adults Women Children under 15 years 3 million 2.4 million 1.1 million 580 000 00002-E-1 – 1 December 2001 Adults and children estimated to be living with HIV/AIDS as of end 2001 North America 940 000 Caribbean 420 000 Latin America 1.4 million Eastern Europe Western Europe & Central Asia 560 000 1 millionEast Asia & Pacific North Africa 1 million South & Middle East & South-East Asia 440 000 6.1 million Sub-Saharan Africa 28.1 million Total: 40 million 00002-E-2 – 1 December 2001 Australia & New Zealand 15 000 Estimated adult and child deaths from HIV/AIDS during 2001 North America 20 000 Caribbean 30 000 Latin America 80 000 Western Europe 6 800 Eastern Europe & Central Asia 23 000 North Africa & Middle East 30 000 Sub-Saharan Africa 35 South & South-East Asia 000 400 000 2.3 million Total: 3 million 00002-E-3 – 1 December 2001 East Asia & Pacific Australia & New Zealand 120 Children (<15 years) estimated to be living with HIV/AIDS as of end 2001 North America 10 000 Caribbean 20 000 Latin America 40 000 Western Europe 4 000 Eastern Europe & Central Asia 15 000 North Africa & Middle East 20 000 sub-Saharan Africa East Asia & Pacific 7 South & South-East Asia 200 000 2.4 million Total: 2.7 million 00002-E-4 – 1 December 2001 000 Australia & New Zealand < 200 About 14 000 new HIV infections a day in 2001 More than 95% are in developing countries 2000 are in children under 15 years of age About 12 000 are in persons aged 15 to 49 years, of whom: — almost 50% are women — about 50% are 15–24 year olds 00002-E-5 – 1 December 2001 Regional HIV/AIDS statistics and features, end of 2001 Epidemic started Adults & children Adults & children newly infected living with HIV/AIDS with HIV % of HIVMain mode(s) of Adult positive prevalence adults who transmission for those rate * are women living with HIV/AIDS ** 8.4% 55% Hetero 28.1 million 3.4 million North Africa & Middle East late ’70s early ’80s late ’80s 440 000 80 000 0.2% 40% Hetero, IDU South and South-East Asia late ’80s 6.1 million 800 000 0.6% 35% Hetero, IDU East Asia & Pacific late ’80s 1 million 270 000 0.1% 20% IDU, Hetero, MSM late ’70s early ’80s late ’70s early ’80s early ’90s 1.4 million 130 000 0.5% 30% MSM, IDU, Hetero 420 000 60 000 2.2% 50% Hetero, MSM 1 million 250 000 0.5% 20% IDU late ’70s early ’80s late ’70s early ’80s late ’70s early ’80s 560 000 30 000 0.3% 25% MSM, IDU 940 000 45 000 0.6% 20% MSM, IDU, Hetero 15 000 500 0.1% 10% MSM 40 million 5 million 1.2% 48% Sub-Saharan Africa Latin America Caribbean Eastern Europe & Central Asia Western Europe North America Australia & New Zealand TOTAL * The proportion of adults (15 to 49 years of age) living with HIV/AIDS in 2001, using 2001 population numbers ** Hetero: heterosexual transmission – IDU: transmission through injecting drug use – MSM: sexual transmission among men who have sex with men 00002-E-6 – 1 December 2001 Changes in life expectancy in selected African countries with high HIV prevalence, 1950 to 2000 65 60 Botswana Uganda South-Africa 55 Zambia 50 Zimbabwe 45 40 35 1950-55 1955-60 1960-65 1965-70 1970-75 1975-80 1980-85 1985-90 1990-95 1995-00 00002-E-7 – 1 December 2001 Source: United Nations Population Division, 1998 Increase in mortality among men between 15 and 60, selected African countries, 1986-1997 80 Probability of dying from all causes estimated for 6 years before survey estimated for year of survey 70 60 50 40 30 20 10 0 Tanzania, 1996 00002-E-8 – 1 December 2001 Malawi, 1992 Zimbabwe, 1994 Uganda, 1995 Source: Timaeus I, AIDS 1998, 12 (suppl): S15-S27 Zambia, 1996-97 Lifetime risk of AIDS death for 15-year-old boys, assuming unchanged or halved risk of becoming infected with HIV, selected countries 100% Risk of dying of AIDS 90% Botswana 80% Zimbabwe 70% 60% 50% 20% Côte d’Ivoire Cambodia Burkina Faso 10% 0% Zimbabwe South Africa Zambia Kenya 40% 30% Botswana South Africa Zambia 0% current level of risk maintained Kenya Côte d’Ivoire Cambodia Burkina Faso 5% 10% 15% 20% 25% 30% Current adult HIV prevalence rate 00002-E-9 – 1 December 2001 risk halved over next 15 years Source: Zaba B, 2000 (unpublished data) 35% 40% Age in years Projected population structure with and without the AIDS epidemic, Botswana, 2020 80 75 70 65 60 55 50 45 40 35 30 25 20 15 10 5 0 Projected population structure in 2020 Males 140 120 100 80 Females 60 40 20 0 20 40 60 80 Population (thousands) 00002-E-10 – 1 December 2001 Source: US Census Bureau, World Population Profile 2000 100 120 140 Deficits due to AIDS HIV prevalence among pregnant women in South Africa, 1990 to 1999 HIV prevalence (%) 25 22.8 22.4 98 99 20 17 14.2 15 10.4 10 7.6 5 4 1.7 2.1 91 92 0.7 0 90 00002-E-11 – 1 December 2001 93 94 95 Source: Department of Health, South Africa 96 97 Predicted loss in life expectancy due to HIV/AIDS in children born in 2000 Predicted life expectancy Loss in life expectancy due to HIV/AIDS Botswana Zimbabwe South Africa Kenya Zambia Côte d'Ivoire Rwanda Mozambique Haiti Cambodia 0 10 20 30 40 Life expectancy at birth (years) 00002-E-12 – 1 December 2001 Source: U.S. Census Bureau, 2000 50 60 70 Impact of HIV/AIDS on urban households, Côte d’Ivoire General population Families living with AIDS 30 000 Francs CFA 25 000 Monthly income per capita 20 000 15 000 Monthly consumption per capita 10 000 5 000 Savings/Disavings 0 – 5 000 00002-E-13 – 1 December 2001 Source: Simulation-based on data from Bechu, Delcroix and Guillaume, 1997 Reduction in production in a household with an AIDS death, Zimbabwe Reduction in output Crops Maize 61% Cotton 47% Vegetables 49% Groundnuts 37% Cattle owned 29% 00002-E-14 – 1 December 2001 Source: Stover & Bollinger, 1999 Affordable prices Annual cost per person for triple therapy in Africa (US$) $12,000 $10,000 Drug Access Initiative $8,000 $6,000 Domestic production $4,000 Accelerated access initiative $2,000 February-April 2001 offers $0 1991 00002-E-15 – 1 December 2001 1993 1995 1997 1999 2001 2003